USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke AVONTEC wurde als Wortmarke am 10.03.2003 beim Amerikanischen Patent- und Markenamt angemeldet. Der aktuelle Status der Marke ist "ABANDONED - AFTER EX PARTE APPEAL".
| Markenform | Wortmarke |
| Aktenzeichen | 76496366 |
| Anmeldedatum | 10. März 2003 |
Markeninhaber
Humboldtallee 23
37073 Gottingen
DE
37073 Gottingen
DE
Markenvertreter
Waren und Dienstleistungen
1
Chemical preparations, namely buffer, lyophilisates, dispersion solutions, emulsions, suspensions, liposomes, additives, polypeptides for scientific purposes; chemical preparations for the investigation and characterization of diseases, namely, of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for scientific purposes
5
Medicaments for the treatment of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; pharmaceutical and veterinary preparations for the control of the expression of genes relevant to said diseases; preparations for diagnosis and analysis of cardiovascular diseases, inflammations, autoimmune diseases, rheumatoid arthritis, psoriasis, gastro-intestinal diseases, Crohn's diseases, ulcerativ colitis, diabetes, nephropathy, retinopathy, vasculopathy, vasculitis, transplant rejections, graft versus host and host versus graft diseases, ischaemia, hypertension, aneurysms, renal failure, pulmonary diseases, infectious and post-infectious diseases, immunological disorders, allergic reactions, coronary heart diseases, restenosis, metabolic disorders, malignancies, except neurological disorders; nucleic acids for medical, analytical and diagnostic purposes
35
Arranging and conducting business conferences
42
Scientific and industrial research and consulting, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; identification of target structures for the development of medicaments, particularly polypeptides and nucleic acids; research and development of new technologies and pharmaceutical products for others, particularly for the control of the expression of genes relevant to diseases; product and technology research and development for others, namely, development of processes and products for scientific and industrial research, particularly in the fields of molecular biology, biotechnology, genetics, medicine and pharmacology; product development in the field of nucleic acids
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1376496366